Literature DB >> 27757533

The challenge of diagnosing a malignancy metastatic to the ovary: clinicopathological characteristics vary and morphology can be different from that of the corresponding primary tumor.

João Lobo1,2,3, Bianca Machado1, Renata Vieira1, Carla Bartosch4,5,6.   

Abstract

An accurate diagnosis of metastases to the ovary is essential for adequate patient management. The aim of this retrospective study was to characterize clinicopathological features of metastatic malignancies that presented as an ovarian mass and compare them with their corresponding primary tumors. We reviewed clinical files and histological material of 120 patients with metastases to the ovary, diagnosed in our center between 2000 and 2014. Metastases were diagnosed before (18 %), synchronously (33 %), or after (49 %) the primary tumor was identified; 25 % were single, 40 % were unilateral; 47 % were ≥13 cm. Most originated from the gastrointestinal tract (73 %), followed by breast (13 %), and female reproductive organs (10 %). Gross features varied with primary tumor site. Metastases from gastrointestinal malignancies were significantly larger and frequently showed necrosis. Metastases to the appendix were cystic (94 %), and almost all metastases to the stomach (96 %) and breast (87 %) were solid. The predominant histological pattern was discordant in 44 % cases, mostly due to cystic changes in ovarian metastases which were observed across several histological types. Other metastases showed a predominant histological pattern which was present only focally in the primary tumor. Metastases showed significantly more edema, necrosis, and hemorrhage, but less lymphovascular invasion and inflammatory infiltrate than the corresponding primary tumors. Metastases to the ovary present highly variable clinicopathological features which frequently differ from those of the corresponding primary tumor. A metastasis should always be considered in the differential diagnosis of an ovarian mass. All clinical, imaging, macroscopic, and histological aspects must be taken into account to establish a correct diagnosis which is essential for adequate treatment.

Entities:  

Keywords:  Heterogeneity; Histopathology; Metastasis; Ovarian neoplasms

Mesh:

Year:  2016        PMID: 27757533     DOI: 10.1007/s00428-016-2029-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  32 in total

Review 1.  Intraoperative consultation in gynecologic pathology.

Authors:  Geza Acs
Journal:  Semin Diagn Pathol       Date:  2002-11       Impact factor: 3.464

2.  Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and laterality.

Authors:  Surapan Khunamornpong; Prapaporn Suprasert; Suwalee Pojchamarnwiputh; Wittanee Na Chiangmai; Jongkolnee Settakorn; Sumalee Siriaunkgul
Journal:  Gynecol Oncol       Date:  2005-11-21       Impact factor: 5.482

Review 3.  Republished: mucinous tumours of appendix and ovary: an overview and evaluation of current practice.

Authors:  Marjan Rouzbahman; Runjan Chetty
Journal:  Postgrad Med J       Date:  2015-01       Impact factor: 2.401

4.  Ovarian metastases of intestinal-type gastric carcinoma: A clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor.

Authors:  Melinda F Lerwill; Robert H Young
Journal:  Am J Surg Pathol       Date:  2006-11       Impact factor: 6.394

Review 5.  Metastatic ovarian tumors: a review of 64 cases.

Authors:  Namiko Yada-Hashimoto; Toshiya Yamamoto; Shoji Kamiura; Hozumi Seino; Hiroki Ohira; Keisuke Sawai; Tadashi Kimura; Fumitaka Saji
Journal:  Gynecol Oncol       Date:  2003-05       Impact factor: 5.482

6.  Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen.

Authors:  D C DeCostanzo; J M Elias; J C Chumas
Journal:  Int J Gynecol Pathol       Date:  1997-07       Impact factor: 2.762

7.  Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.

Authors:  Anna V Yemelyanova; Russell Vang; Kara Judson; Lee-Shu-Fune Wu; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2008-01       Impact factor: 6.394

Review 8.  A practical approach to intraoperative consultation in gynecological pathology.

Authors:  Patricia Baker; Esther Oliva
Journal:  Int J Gynecol Pathol       Date:  2008-07       Impact factor: 2.762

Review 9.  From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.

Authors:  Robert H Young
Journal:  Adv Anat Pathol       Date:  2007-05       Impact factor: 3.875

10.  Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.

Authors:  Kara Judson; Colleen McCormick; Russell Vang; Anna V Yemelyanova; Lee-Shu-Fune Wu; Robert E Bristow; Brigitte M Ronnett
Journal:  Int J Gynecol Pathol       Date:  2008-04       Impact factor: 2.762

View more
  3 in total

1.  A case report of appendiceal adenocarcinoma without gastrointestinal evidence mimicking primary ovarian cancer.

Authors:  Chih-Wei Lin; Shu-Ling Peng; Shu-Hsien Wang; Pei-Ying Wu
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.671

2.  Incidental diagnosis of breast cancer in the pursuit of the treatment of intestinal obstruction.

Authors:  Isabel Armas; Mariana Brandão; Inês Guerreiro; Inês Guerreiro; João Lobo; Carla Freitas; João Pinto-de-Sousa; Joaquim Abreu de Sousa
Journal:  Autops Case Rep       Date:  2019-02-25

Review 3.  Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics.

Authors:  Pavel Dundr; Naveena Singh; Barbora Nožičková; Kristýna Němejcová; Michaela Bártů; Ivana Stružinská
Journal:  Diagn Pathol       Date:  2021-03-11       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.